How has been the historical performance of M K Proteins?
M K Proteins has experienced fluctuating financial performance, with net sales declining from 314.86 Cr in Mar'23 to 267.71 Cr in Mar'25, and a decrease in profit after tax to 8.40 Cr in Mar'25 from 11.21 Cr in Mar'24. Key metrics such as operating profit and earnings per share also fell, indicating significant financial challenges.
Answer:The historical performance of M K Proteins shows a fluctuating trend in net sales and profitability over the years, with net sales reaching 267.71 Cr in Mar'25, up from 245.57 Cr in Mar'24, but down from 314.86 Cr in Mar'23. The total operating income mirrored this trend, with a total of 267.71 Cr in Mar'25 compared to 245.57 Cr in Mar'24. The company faced a significant drop in raw material costs from 205.72 Cr in Mar'24 to 166.74 Cr in Mar'25, contributing to a total expenditure of 255.28 Cr in Mar'25, which was higher than 228.95 Cr in Mar'24. Operating profit (PBDIT) decreased to 12.91 Cr in Mar'25 from 17.07 Cr in Mar'24, reflecting a decline in operating profit margin to 4.64%. Profit before tax also fell to 11.45 Cr in Mar'25 from 15.47 Cr in Mar'24, leading to a profit after tax of 8.40 Cr in Mar'25, down from 11.21 Cr in Mar'24. The earnings per share dropped significantly to 0.22 in Mar'25 from 0.30 in Mar'24, indicating a challenging year for the company.Breakdown:
M K Proteins experienced a decline in net sales from 314.86 Cr in Mar'23 to 267.71 Cr in Mar'25, despite a slight increase from 245.57 Cr in Mar'24. The total operating income followed a similar pattern, reflecting the company's struggles with profitability as operating profit (PBDIT) decreased from 17.07 Cr in Mar'24 to 12.91 Cr in Mar'25. The operating profit margin also fell to 4.64%, indicating reduced efficiency. Profit before tax decreased to 11.45 Cr in Mar'25, leading to a profit after tax of 8.40 Cr, both lower than the previous year. The earnings per share saw a significant drop to 0.22 in Mar'25 from 0.30 in Mar'24, highlighting the financial challenges faced by the company. Overall, M K Proteins has shown volatility in its financial performance, with notable declines in key metrics over the last two years.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
